Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-08 | New | $25,425,442 | $25,425,442 | Debt Only | 06b | SEC link |
| 2024-07-29 | Amended | $48,540,780 | $20,508,787 | Equity Only | 06b | SEC link |
| 2024-02-14 | New | $1,187,700 | $1,187,700 | Other | 06b | SEC link |
| 2024-02-14 | New | $3,296,554 | $3,296,554 | Other | 06b | SEC link |
| 2023-08-11 | New | $28,031,993 | $28,031,993 | Equity Only | 06b | SEC link |
| 2021-03-31 | New | $29,999,988 | $29,999,988 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Lisa Alderson | Director, Executive |
| David Bonita | Director |
| Scott Bratman | Director, Executive, Promoter |
| Paul Brown | Director |
| Daniel De Carvalho | Executive |
| Daniel Diniz De Carvalho | Executive, Promoter |
| Andrew El Bardissi | Director |
| Anne Renee Hartman | Executive |
| Anne Renee Hartman Feldman | Executive |
| Priscilla Huang | Executive |
| Maneesh Jain | Director, Promoter |
| Karla Jarvis | Executive |
| Christopher Parker | Executive |
| David Scheer | Director, Executive, Promoter |
| Robert Weisskoff | Director |
| Alan Williams | Executive |